Exchange: NYSE·Updated 07:58 PM EDT
RMD logo

RMDResmed Inc.

$188.63
$2.34
(1.26%)
Today
Closed $188.63
$1.57
(0.83%)
After Hours
EarningsAug 6
Mkt Cap$27.36B
Vol3.88M
35

Bearish Sentiment

How do you feel about RMD?

News
all
press releases
Here's How Much You Would Have Made Owning ResMed Stock In The Last 20 Years
ResMed (NYSE:RMD) has outperformed the market over the past 20 years by 1.89% on an annualized basis producing an average annual return of 11.28%. Currently, ResMed has a market capitalization of $27.48 billion. Buyingread more...
Benzinga
News Placeholder
More News
News Placeholder
This ResMed Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Wall Street analysts changed outlook on top names. Check analyst ratings page for upgrades, downgrades, initiations. See opinions on EFC stock.read more...
Benzinga
News Placeholder
Futures Fade Overnight Gains As Attention Turns To Kevin Warsh's First Fed Decision
Futures Fade Overnight Gains As Attention Turns To Kevin Warsh's First Fed Decision US futures are attempting to bounce back from yesterday's losses on Wall Street?led by Tech. As of 8:00am ET,?Nasdaq 100 futures lead the charge, with gains of 0.5% versus 0.1% for the S&P 500 future...
Zero Hedge
News Placeholder
Why ResMed (RMD) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
News Placeholder
Is ResMed Inc. (RMD) A Good Stock To Buy Now?
Is ResMed Inc. (RMD) A Good Stock To Buy Now...
Yahoo! Finance: News
News Placeholder
Is This the Right Time to Retain Resmed Stock in Your Portfolio?
RMD gains from acquisition-led Residential Care Software growth, mask innovation and strong finances but faces macro and competitive pressures.
Zacks
News Placeholder
ResMed (RMD) is a Top-Ranked Growth Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
News Placeholder
Is the Options Market Predicting a Spike in ResMed Stock?
Investors need to pay close attention to RMD stock based on the movements in the options market lately.
Zacks
News Placeholder
Silver Economy Investing: Why the Healthcare Giants Are in Focus
Healthcare giants like Eli Lilly, Tandem Diabetes, Intuitive Surgical and ResMed are tapping aging-driven demand in obesity, surgery and sleep care.
Zacks
News Placeholder
Here's Why ResMed (RMD) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
<
1
2
...
>

Advertisement|Remove ads.